Researchers say they have discovered a new class of antibiotics that could treat drug-resistant bacteria.  The new molecule, ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

Even better, they discovered that lariocidin—named for its knotted, lasso-like chemical structure—has a unique mechanism of ...

Saccharin destabilizes bacterial membranes and interferes with DNA replication, causing lysis and impairing virulence traits.

The novel antibiotic class could be active against the vast majority of multidrug-resistant Enterobacterales infections.

Arrepath Inc. has disclosed UDP-2,3-diacylglucosamine hydrolase (LpxH; bacterial) inhibitors reported to be useful for the treatment of gram-negative bacterial infections.

BioVersys AG / Key word (s): Patent BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE 31-March-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR ...

Antimicrobial resistance is a global issue, making the search for a new generation of antibiotics imperative. Scientists investigate various compounds to discover new antibiotics, one class of which ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...